APA (7th ed.) Citation

J, S., J, A., R, M., K, R., S, P., L, S., . . . KJ, E. (2025). A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease. EBioMedicine, 113, 105570. https://doi.org/10.1016/j.ebiom.2025.105570

Chicago Style (17th ed.) Citation

J, Sanderson, et al. "A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of Simian Adenovirus and Poxvirus Vectored Vaccines Against a Mycobacterium Avium Complex Subspecies in Patients with Active Crohn's Disease." EBioMedicine 113 (2025): 105570. https://doi.org/10.1016/j.ebiom.2025.105570.

MLA (9th ed.) Citation

J, Sanderson, et al. "A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of Simian Adenovirus and Poxvirus Vectored Vaccines Against a Mycobacterium Avium Complex Subspecies in Patients with Active Crohn's Disease." EBioMedicine, vol. 113, 2025, p. 105570, https://doi.org/10.1016/j.ebiom.2025.105570.